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Abstract
Introduction: Chagas disease (CD), a neglected endemic disease in Latin America, has acquired new epidemiological 
characteristics with an increase in the importance of alternative transmission routes such as congenital transmission. We 
evaluated the scientific research on this subject. Methods: We searched the Scielo, BVS, and PubMed databases from 2006 to 
2017. Results: We identified a small number of published articles, mostly in journals with an impact factor less than 3.0. Studies 
on human congenital transmission of CD were carried out in only seven different countries. Conclusions: Our data highlight the 
lack of research on congenital CD.
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Chagas disease (CD), or American trypanosomiasis, is an 
endemic disease in Latin America classified as a neglected 
tropical disease by the World Health Organization (WHO). 
Approximately seven million people are infected with 
Trypanosoma cruzi worldwide, with the main concentration in 
Brazil, Mexico, and Argentina1. Globalization and the intense 
flow of people through countries, especially Latino immigrants, 
contribute to the spread of infection to non-endemic areas2,3. 
In the acute phase of the disease, patients may present several 
clinical manifestations, among them fever, hepatomegaly, 
splenomegaly, swelling at the inoculation site (chagoma of 
inoculation), and edema of the eyelid (Romana sign)2. Most 
infected patients, however, are asymptomatic. In approximately 
one-third of patients, the disease evolves into a symptomatic 
chronic phase, with clinical manifestations related specifically 
to the cardiovascular and digestive system4.
Infected hematophagous Hemiptera of the subfamily 
Triatominae can transmit the protozoa T. cruzi naturally to 
man and other animals. Alternative transmission routes are 
blood transfusion, organ transplantation, and sexual, oral, and 
congenital routes. Since classical forms of CD transmission such 
as vector and blood transfusion are being controlled, other less 
frequent forms of transmission such as congenital transmission 
have been showing increasing epidemiological importance.
Mother-to-child T. cruzi transmission may result in 
premature births, low-weight newborns, and stillbirths5. Since 
its description by Carlos Chagas in 19116, several authors have 
reported the importance of CD congenital transmission, not only 
experimentally, but mainly in man4. Currently, the congenital 
transmission rate varies greatly depending on the location, being 
approximately 1% in Brazil and reaching 12% in other Latin 
American countries7. It is estimated that, in endemic regions, 
approximately two million women of childbearing age have 
the chronic form of the disease, with an estimated incidence of 
15,000 cases per year in Latin America8.
Data on congenital transmission of CD are heterogeneous, 
being influenced by the form of control and diagnostic and 
screening programs, which reinforces the need to intensify the 
studies and research of patients suspected to have the disease. 
Despite generating more work and costs, these actions would 
have the benefit of decreasing the number of infected children 
and if the child is treated up to 1 year of age, the chance of a 
cure is higher8,9. In this respect, the quality of the tests used for 
diagnosis is of great importance and may be fundamental to 
guarantee the early detection of congenital CD transmission. 
Unfortunately, from a political point of view, CD is considered 
a Latin American problem and has not attracted the attention 
of major world research centers.
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In this context, the objective of this work was to evaluate the 
scientifi c research on this subject by identifying the number of 
published articles, the impact factors of the journals in which 
the articles were published, and the countries where the research 
was carried out.
A systematic review on congenital transmission of CD 
was carried out using the Virtual Health Library (BVS), the 
Scientific Electronic Library Online (Scielo), and Public 
Medline (PubMed), on February 23, March 3, and February 
13 in 2017 and on January 24 in 2018. The study period was 
from 2006 to 2017 and the descriptors used were "Chagas 
disease,” “congenital transmission,” “Trypanosoma cruzi,” 
and “pregnancy.”
We established the following inclusion criteria: (1) studies 
involving congenital transmission of CD, (2) studies conducted in 
humans, and (3) articles written in English. The following types 
of study were excluded: case reports, review studies, dissertations 
and theses, studies without epidemiological and diagnostic aspects, 
and studies performed in animals or in vitro. Within the established 
study period, 97 articles were found in PubMed, 91 in the BVS 
database, excluding those in duplicate, result in 100 articles, and no 
articles on Scielo. After a thorough analysis of the found articles, 
32 were eligible for the study proposal, as shown in Figure 1.  
The following bibliometric indicators were evaluated: 
number of papers published, names of journals and their 
respective impact factors, year of publication, countries where 












































surveys were conducted, sample size, congenital transmission 
incidence, and diagnosis methods. 
After analyzing all the inclusive and exclusive criteria of the 
articles, the selected publications were organized and arranged 
in chronological order, as shown in Table 1, from the most 
recent (2017) to the oldest (2007). Despite the search for articles 
from 2006, no article fit within the inclusion criteria in the first 
year. The 32 selected articles were distributed in 12 different 
journals with impact factors varying between 1.631 and 8.736. 
The journals with the most published articles Acta Tropica and 
The American Journal of Tropical Medicine and Hygiene, with 
six articles in each journal. There were few articles between the 
years 2006 and 2009, but more in the years 2012 and 2015 (five 
and seven articles, respectively). 
Another aspect evaluated was the distribution of the research 
by country (Table 1). Studies on congenital transmission 
of CD were carried out in only seven different countries, 
with predominance in Argentina (10 studies), Bolivia (eight 
studies), and Spain (five studies). Of interest, a single study was 
conducted in Brazil. In relation to the research time span, short-
term and long-term studies were identified, the largest being a 
retrospective 20-year study (Table 1). Of the 30 studies, only 
one did not report the coverage period.
As noted in Table 2, there was a large variation in the sample 
size among the articles, ranging from 19 to 4355 children. The 
incidence of CD congenital transmission also differed among the 
studies, independently of the study area endemicity. In the nine 
studies conducted in non-endemic areas (four in Buenos Aires 
and five in Spain), the congenital transmission rate ranged from 
2.6% in Spain to 23% in Buenos Aires. In these areas, 55.5% of 
studies had a transmission rate ≥5%. Of interest, the majority 
of these mothers came from endemic areas of Latin America 
(Table 2). The congenital transmission rate in the endemic areas 
varied from 1.98% to 20% in studies carried out, respectively, 
in Brazil and in Mexico. 
The articles we analyzed demonstrated a gamut of 
methodologies used for the diagnosis of congenital transmission 
of CD. Indeed, 90% (27/30) of the articles used more than 
one methodology: parasitological, serological, or molecular, 
according to WHO recommendations. 
For the present study, we conducted a literature review to 
identify articles published in the last 10 years on CD congenital 
transmission, using predetermined inclusion and exclusion 
criteria. At the end of the analysis, 32 articles were selected 
for content evaluation. Most articles (21/32) were published 
in the last 5 years; but in 2016, only one article was selected 
within the pre-established criteria. In this respect, it should be 
TABLE 1: Bibliometric indicators of the reviewed articles on congenital Chagas disease. 
Reference Article Journal/impact factor Country Research time span
Murcia et al., 
2017
Treatment of Infected Women of Childbearing Age Prevents 
Congenital Trypanosoma cruzi Infection by Eliminating the 







Congenital Transmission of Trypanosoma cruzi in Argentina, 
Honduras, and Mexico: An Observational Prospective Study
The American Journal 





Rincón et al., 
2016
Trypanosoma cruzi seroprevalence in pregnant women and 




Vargas et al., 
2015
Seroprevalence of Trypanosoma cruzi Infection in 
Schoolchildren and in Pregnant Women from an Amazonian 
Region in Orellana Province, Ecuador
The American Journal 





Sustained Domestic Vector Exposure Is Associated with 
Increased Chagas Cardiomyopathy Risk but Decreased 





Volta et al., 
2015
Diagnosis of congenital Trypanosoma cruzi infection: A 






Luquetti et al., 
2015
Congenital transmission of Trypanosoma cruzi in central 
Brazil. A study of 1,211 individuals born to infected mothers
Memórias do Instituto 
Oswaldo Cruz/1.789 Brazil 1994-2014
Rendell et al., 
2015
Trypanosoma cruzi-Infected Pregnant Women without Vector 
Exposure Have Higher Parasitemia Levels: Implications for 
Congenital Transmission Risk
PLOS One/4.411 Bolivia 2010-2011
Moscatelli et 
al., 2015
Urban Chagas disease in children and women in primary 
care centres in Buenos Aires, Argentina





Arandes et al., 
2014
Controlling congenital and paediatric Chagas disease through 
a community health approach with active surveillance and 
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Reference Article Journal/impact factor Country Research time span
Fabbro et al., 
2014
Trypanocide treatment of women infected with Trypanosoma 
cruzi and its effect on preventing congenital Chagas
PLOS Neglected 
Tropical Disease/4.446 Argentina 2012-2013
Velázquez et 
al., 2014
Predictive role of polymerase chain reaction in the early 





Bua et al., 
2013
How to improve the early diagnosis of Trypanosoma cruzi 
infection: relationship between validated conventional 
diagnosis and quantitative DNA amplification in congenitally 
infected children
PLOS Neglected 
Tropical Disease/4.446 Argentina 2008-2011
Murcia et al., 
2013
Risk factors and primary prevention of congenital Chagas 
disease in a nonendemic country
Clinical Infectious 
Diseases/8.736 Spain 2007-2011
Apt et al., 
2013
Congenital infection by Trypanosoma cruzi in an endemic 
area of Chile: a multidisciplinary study
Transactions of the 
Royal Society of 
Tropical Medicine and 
Hygiene/1.631
Chile 2006-2009
Duffy et al., 
2013
Analytical Performance of a Multiplex Real-Time PCR Assay 
Using TaqMan Probes for Quantification of Trypanosoma 
cruzi Satellite DNA in Blood Samples
PLOS Neglected 
Tropical Disease/4.446 Argentina 2011-2012
Ortiz et al., 
2012
Presence of Trypanosoma cruzi in pregnant women and 
typing of lineages in congenital cases
Journal Acta 
Tropica/2.380 Chile 2006-2010
Otero et al., 
2012
Congenital transmission of Trypanosoma cruzi in non-
endemic areas: evaluation of a screening program in a 
tertiary care hospital in Barcelona, Spain
The American Journal 
of Tropical Medicine 
and Hygiene/2.456
Spain 2008-2010
Clavijo et al., 
2012
Prevalence of Chagas disease in pregnant women and 






Prevalence of Trypanosoma cruzi infection in pregnant Latin 
American women and congenital transmission rate in a 




Cardoso et al., 
2012
Maternal fetal transmission of Trypanosoma cruzi: a problem 
of public health little studied in Mexico
Experimental 
Parasitology/1.623 Mexico 2006-2008
Bisio et al., 
2011
Urbanization of congenital transmission of Trypanosoma 
cruzi: Prospective polymerase chain reaction study in 
pregnancy
Transactions of the 
Royal Society of 






Surveillance of Chagas disease in pregnant women in 
Madrid, Spain, from 2008 to 2010 Eurosurveillance/5.98 Spain 2008-2010
Romero et al., 
2011
Door-to-door screening as a strategy for the detection of 
congenital Chagas disease in rural Bolivia





Brutus et al., 
2010
Detectable Trypanosoma cruzi Parasitemia during Pregnancy 
and Delivery as a Risk Factor for Congenital Chagas Disease
The American Journal 
of Tropical Medicine 
and Hygiene/2.453
Bolivia 2004-2005
Rissio et al., 
2010
Congenital Trypanosoma cruzi Infection. Efficacy of Its 
Monitoring in an Urban Reference Health Center in a Non-
Endemic Area of Argentina
The American Journal 





Early diagnosis of congenital Trypanosoma cruzi infection, 
using shed acute phase antigen, in Ushuaia, Tierra del 
Fuego, Argentina
The American Journal 
of Tropical Medicine 
and Hygiene/2.453
Argentina 2001-2002
Apt et al., 
2010
Vertical transmission of Trypanosoma cruzi in the Province of 
Choapa, IV Region, Chile. Preliminary Report (2005-2008)
Biological 
Research/1.328 Chile 2006-2008
Bern et al., 
2009




Diez et al., 
2008
The Value of Molecular Studies for the Diagnosis of 
Congenital Chagas Disease in Northeastern Argentina
The American Journal 
of Tropical Medicine 
and Hygiene/2.453
Argentina ND
Brutus et al., 
2008
Congenital Chagas disease: Diagnostic and clinical aspects 
in an area without vectorial transmission, Bermejo, Bolivia
Journal Acta 
Tropica/2.380 Bolivia 2002-2004
Salas et al., 
2007
Risk factors and consequences of congenital Chagas disease 
in Yacuiba, south Bolivia
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TABLE 2: Epidemiological aspects of congenital Chagas disease in selected articles.
Reference Sample size (child) Incidence of congenital transmission Endemic area? Maternal nationality
Murcia et al., 2017 160 10% No Bolivia
Buekens et al., 2017 503
0% Honduras, 6.6% 
Argentina, and 6.3% 
Mexico
Yes Honduras, Argentina, Mexico
Montes-Rincón et al., 2016 20 20% Yes Mexico
Vargas et al., 2015 1649 ND Yes Ecuador
Kaplinski et al., 2015 1000 6.8% Yes Bolivia
Volta et al., 2015 91 23% No 69.23% Argentina; 18.68% Bolivia;  12% Paraguay
Luquetti et al., 2015 1212 1.98% Yes Brazil
Rendell et al., 2015 135 11.7% Yes Bolivia
Moscatelli et al., 2015 19 Varied Yes 58.7% Argentina; 17% Bolivia;  12.4% Peru; 10% Paraguay
Soriano-Arandes et al., 2014 42 6.9% No 90.5% Bolivia
Fabbro et al., 2014 354 15.3% No 85% Argentina; 10% Bolivia;  4% Paraguay
Velázquez et al., 2014 468 10.47% No 63.5% Argentina; 26.8% Bolivia;  8.2% Paraguay
Bua et al., 2013 843 11.27% No 60% Argentina; 35% Bolivia;  5% Paraguay
Murcia et al., 2013 65 13.8% No 96.6% Bolivia; 3.4% Paraguay
Apt et al., 2013 4280 4.7% Yes Chile
Duffy et al., 2013 74 4.05% Yes Argentina
Ortiz et al., 2012 100 3% Yes Chile
Otero et al., 2012 20 5% No 34% Equador; 18% Bolivia; 13% Peru
Clavijo et al., 2012 3579 3.4% Yes ND
Barona-Vilar et al., 2012 217 14.15% No 30% Equador; 21.7% Bolivia,  17.8% Colombia; 6.4% Argentina
Cardoso et al., 2012 106 4.7% Yes ND
Bisio et al., 2011 83 2.6% No
37.5% Argentina; 24% Bolivia; 23.1% 
Paraguay; 1% Peru;  
14.4% indeterminate
Flores-Chavez et al., 2011 152 5% No 44.4% Bolivia
Romero et al., 2011 299 7.48% Yes Bolivia
Brutus et al., 2010 147 6.1% Yes Bolivia
Rissio et al., 2010 4355 4.4% Yes Argentina
Mallimaci et al., 2010 68 2.5% Yes Argentina
Apt et al., 2010 80 2.5% Yes Chile
Bern et al., 2009 138 6.4% Yes Bolivia
Diez et al., 2008 121 9.9% Yes Argentina
Brutus et al., 2008 231 5.2% Yes Bolivia
Salas et al., 2007 2742 5.1% Yes Bolivia
ND: not determined.
emphasized that continuous research is extremely important for 
an understanding of the biological and clinical aspects of a disease 
and is dependent on the interest of development agencies and the 
scientific community. Regarding CD, one of the most widespread 
diseases in the Americas, significant advances in different areas 
are still lacking, such as the knowledge of its pathogenesis, the 
development of new treatments, and the follow-up of congenital 
transmission cases10-13. Such limitations are associated with 
the fact that CD presents important sociocultural and political-
economic aspects that do not attract investments.
Few are the well-qualified journals that currently contribute 
significantly to the dissemination of scientific research on CD. 
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Our review identified articles in 12 different journals with impact 
factors between 1.631 and 8.736, suggesting a lack of interest of 
the scientific community in the topic. Only 10% of the articles 
were published in journals with an impact factor greater than 
5.0. As trypanosomiasis occurs mainly in one of the poorest parts 
of the world, it does not have the same repercussion as other 
more widely distributed protozoa, such as malaria. Therefore, 
it represents a regional problem, naturally generating greater 
interest only in Latin America. This, in turn, explains why 
most of the studies were conducted in Argentina and Bolivia. 
Nevertheless, there was some interest in the subject in Spain, 
the only European country with identified articles (five). The 
increased interest in non-endemic areas may be associated with 
a greater occurrence of CD congenital transmission in these 
localities owing to extensive migration, reaching European 
and Asian countries as well as cities and states without vector 
transmission3,14.
Among the endemic localities, Bolivia was the country 
with the most studies performed as well as the country with 
the greatest impact on congenital transmission in non-endemic 
areas, which corroborates the fact that the largest number of 
immigrants in Europe with CD are Bolivians3. Strangely enough, 
only one study fulfilling the pre-defined criterion was carried 
out in Brazil. According to the 2nd Brazilian Consensus on CD, 
although Brazil has advanced in vector and blood bank control, 
over the years, Brazil has had few published studies on CD, 
making it difficult to systematize data on this topic15. Despite 
being considered a compulsory notification disease, according 
to the Brazilian Consensus, Brazil does not provide any specific 
surveillance of pregnant women or children. 
On the other hand, even though CD does not receive the 
desired attention, it has an important role in the maturing Latin 
American scientific community, which has been responsible for 
the main findings of this disease, including its discovery. Thus, 
we expect CD to continue to be a driving force in Latin American 
research, helping to solve social problems and contributing to 
expand the knowledge about this endemic disease.
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